Gilead-Kite Oncology is focused on delivering therapies for some of the most difficult-to-treat cancers. We create and deliver transformative therapies across complementary and novel platforms, including Gilead’s two new approvals with an innovative antibody-drug conjugate and Kite’s industry-leading cell therapy franchise across three approved indications. We are pleased to share our progress in developing treatments for people living with cancer.
Brands: https://mwsgblprod-cdne.azureedge.net/PTFP1135_ASCObooth_Header_1140x250.png
Show Specials
Press Releases
Products